Get started
Author

S. S. Jhee

Pharmacokinetics and Pharmacodynamics of the Novel Daily Rivastigmine Transdermal Patch Compared With Twice-daily Capsules in Alzheimer's Disease Patients
2007 · G Lefèvre, G Sędek, et al. · Clinical Pharmacology & Therapeutics · 130
Dose-dependent CSF acetylcholinesterase inhibition by SDZ ENA 713 in Alzheimer's disease
2009 · N. R. Cutler, R. J. Polinsky, et al. · Acta Neurologica Scandinavica · 123
Low Penetration of Oseltamivir and Its Carboxylate into Cerebrospinal Fluid in Healthy Japanese and Caucasian Volunteers
2008 · S. S. Jhee, M. Yen, et al. · Antimicrobial Agents and Chemotherapy · 57
Pharmacokinetic‐Pharmacodynamic Modeling of Rivastigmine, a Cholinesterase Inhibitor, in Patients with Alzheimer's Disease
2001 · J.V.S. Gobburu, V Tammara, et al. · The Journal of Clinical Pharmacology · 47
Multiple‐Dose Plasma Pharmacokinetic and Safety Study of LY450108 and LY451395 (AMPA Receptor Potentiators) and Their Concentration in Cerebrospinal Fluid in Healthy Human Subjects
2006 · S. S. Jhee, A. S. Chappell, et al. · The Journal of Clinical Pharmacology · 32
Penetration of trovafloxacin into cerebrospinal fluid in humans following intravenous infusion of alatrofloxacin
1997 · N R Cutler, J Vincent, et al. · Antimicrobial Agents and Chemotherapy · 30
Similarity of Insulin Detemir Pharmacokinetics, Safety, and Tolerability Profiles in Healthy Caucasian and Japanese American Subjects
2004 · Stan S. Jhee, William H. Lyness, et al. · The Journal of Clinical Pharmacology · 23
P4‐366: GSI‐953, a potent and selective gamma‐secretase inhibitor: Modulation of beta‐amyloid peptides and plasma and cerebrospinal fluid pharmacokinetic/pharmacodynamic relationships in humans
2008 · Glen Frick, Sangeeta Raje, et al. · Alzheimer s & Dementia · 18
Dihydroxyphenylglycol as a Biomarker of Norepinephrine Transporter Inhibition by Atomoxetine
2016 · Peter R. Bieck, Mark Leibowitz, et al. · Journal of Clinical Psychopharmacology · 8
Safety and Tolerability of Serial Cerebrospinal Fluid (CSF) Collections During Pharmacokinetic/Pharmacodynamic Studies: 5 Years Experience
2003 · S. S. Jhee, V. Zarotsky · Clinical Research and Regulatory Affairs · 8
529. Pharmacokinetics of rivastigmine and its metabolite in patients with Alzheimer’s disease
2000 · N.R. Cutler, M. Hossain, et al. · Biological Psychiatry · 4
Strategies to accelerate drug development for CNS compounds
2011 · Larry Ereshefsky, Stan Jhee, et al. · International Clinical Psychopharmacology · 1
157. NXX-066 in patients with Alzheimer's disease: A bridging study
1998 · N.R. Cutler, G. Friday, et al. · Biological Psychiatry · 1
P1‐365: a Comparison of in Vivo Potency in Two Bace Inhibitors as Determined in Humans and Dogs
2014 · Brian A. Willis, Patrick C. May, et al. · Alzheimer s & Dementia
Cerebrospinal fluid pharmacokinetics of LY450108 in healthy human subjects
2003 · S.S. Jhee, S. Chalon, et al. · Clinical Pharmacology & Therapeutics
Works count: 17
Citation count: 483
H-index: 8
I10-index: 8
Year
Topic
Type